サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404775

日本の次世代シーケンシング市場規模、シェア、動向分析レポート：技術別、製品別、用途別、ワークフロー別、最終用途別、セグメント予測、2024年～2030年

Japan Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (Targeted Sequencing & Resequencing), By Product (Platforms, Consumables) By Application, By Workflow, By End-use, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
日本の次世代シーケンシング市場規模、シェア、動向分析レポート：技術別、製品別、用途別、ワークフロー別、最終用途別、セグメント予測、2024年～2030年
出版日: 2023年11月27日
発行: Grand View Research
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

日本の次世代シーケンシング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、日本の次世代シーケンシング市場規模は2024年から2030年にかけて23.60%のCAGRを記録し、2030年には13億567万米ドルに達すると予測されています。

コンパニオン診断や個別化医療の発展、NGS技術の臨床機会の増加などの要因が市場成長を促進すると予測されています。さらに、高い消費者需要に起因する市場競争の激化や、次世代シーケンシング製品およびサービスの開発に重点を置く市場プレイヤーの台頭も、業界の需要を前進させる重要な要因です。

コストの低下により、臨床現場での次世代シーケンシングの採用が加速しています。さらに、クリニックベースのNGSソリューションに対する需要の増加は、予測期間にわたって次世代シーケンシング業界を推進すると予想されています。ゲノムシーケンスとMPSS/NGSの活用は、希少疾患の診断と解析、治療標的の認識、出生前検査に必要となっています。NGSは、遺伝性疾患や感染症治療において採用が増加すると予想されます。さらに、企業は希少疾患や遺伝性疾患向けにNGSに基づく製品やサービスを提供しています。例えば、2023年1月、日本のNGSサービスプロバイダーであるツイストバイオサイエンス株式会社は、遺伝性がん研究および希少疾患をサポートし、診断を支援する3つのNGSターゲット濃縮パネルを発表しました。国内で事業を展開する主要企業によるこのような製品発表は、予測期間中の市場成長を促進すると予想されます。

コンパニオン診断や個別化医療の発展が、次世代シーケンシング製品やサービスの採用を促進すると予想されます。複数の腫瘍専門医は、コンパニオン診断と組み合わせたNGSが個別化診断および治療において大きな役割を果たし、NGSアプリケーションの需要が大幅に増加すると予想しています。さらに、規制当局もコンパニオン診断へのNGSの使用を支持しています。例えば、2021年9月、日本の厚生労働省はサーモフィッシャーサイエンティフィック社のコンパニオン診断薬（CDx）であるOncomine Dx Target Testを承認しました。オンコミン検査は、肺がんのNGSベースのCDxとして承認されました。このような新興国市場の開拓は、規制当局の支援と相まって、予測期間中の市場成長を後押しすると予想されます。

日本の次世代シーケンシング市場レポートハイライト

  • 製品別では、消耗品セグメントが2023年の売上高シェア74.0%で業界を支配しており、この支配はシーケンスコストの低下と大手企業による消耗品の発売増加によるものと考えられます。
  • 用途別では、2023年に腫瘍学分野が業界最大の収益貢献者でした。対照的に、消費者ゲノミクスセグメントは、個人の健康意識、父子関係検査、家系図作成の急速な発展により、最も速い成長が期待されています。
  • ワークフローに基づくと、シーケンシングセグメントが2023年の市場を独占しました。このセグメントの収益が高いのは、さまざまなシーケンスプラットフォームが利用可能なためです。
  • 技術別では、ターゲットシーケンス＆リシーケンスセグメントが2023年に業界を支配し、予測期間中に最も高い成長率を記録すると予測されています。
  • 最終用途に基づくと、多くの学術機関がバイオインフォマティクスコースを提供しているため、学術研究セグメントが2023年に業界を支配しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 日本の次世代シーケンシング市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 日本の次世代シーケンシング市場分析ツール
    • SWOT分析;要因別（政治的、法律的、経済的、技術的）
    • ポーターのファイブフォース分析
    • COVID-19感染症の影響分析

第4章 日本の次世代シーケンシング市場：技術ビジネス分析

  • 次世代シーケンシング市場：技術変動分析
  • ターゲットシーケンシングとリシーケンシング
  • 全ゲノム配列決定
  • 全エクソームシーケンス

第5章 日本の次世代シーケンシング市場：製品ビジネス分析

  • 次世代シーケンシング市場：製品の変動分析
  • プラットフォーム
  • 消耗品
    • サンプル調製
    • ターゲットの強化
    • その他

第6章 日本の次世代シーケンシング市場：用途ビジネス分析

  • 次世代シーケンシング市場：用途の変動分析
  • オンコロジー
    • 診断とスクリーニング
    • 調査研究
  • 臨床調査
    • 感染症
    • 特発性疾患
    • 遺伝性疾患
    • 非伝染性疾患/その他の病気
  • リプロダクティブ・ヘルス
    • NIPT
    • PGT
    • 新生児遺伝子スクリーニング
    • 単一遺伝子解析
  • HLAタイピング/免疫システムモニタリング
  • メタゲノミクス、疫学、創薬
  • アグリゲノミクスと法医学
  • 消費者ゲノミクス

第7章 日本の次世代シーケンシング市場：ワークフロービジネス分析

  • 次世代シーケンシング市場：ワークフロー変動分析
  • プリシーケンシング
  • シーケンシング
  • データ分析
    • 一次データNG分析
    • 二次データ分析
    • 三次データ分析

第8章 日本の次世代シーケンシング市場：最終用途ビジネス分析

  • 次世代シーケンシング市場：最終用途の変動分析
  • 学術調査
  • 臨床調査
  • 病院とクリニック
  • 製薬およびバイオテクノロジー企業
  • その他のユーザー

第9章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
  • 主要企業の市場シェア分析、2023年
  • Participants Overview
    • Illumina, Inc
    • QIAGEN
    • Thermo Fisher Scientific, Inc
    • BGI
    • Pacific Biosciences
    • Bio Rad Laboratories
    • Oxford Nanopore Technologies, Inc
    • Myriad Genetics. Inc.
    • Agilent Technologies, Inc.
    • Eurofins Scientific
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 Japan next generation sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 3 Japan next generation sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 4 Japan next generation sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 5 Japan next generation sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 Japan next generation sequencing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Japan next generation sequencing market: market outlook
  • Fig. 7 Japan next generation sequencing competitive insights.
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook.
  • Fig. 10 Penetration and growth prospect mapping
  • Fig. 11 Industry value chain analysis
  • Fig. 12 Japan next generation sequencing market driver impact
  • Fig. 13 Japan next generation sequencing market restraint impact
  • Fig. 14 Japan next generation sequencing market strategic initiatives analysis
  • Fig. 15 Japan next generation sequencing market: Technology movement analysis
  • Fig. 16 Japan next generation sequencing market: Technology outlook and key takeaways
  • Fig. 17 Targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 DNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 RNA -based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Whole genome sequencing market estimates and forecast, 2018-2030 (USD Million)
  • Fig. 21 Whole exome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Japan Next-generation sequencing market: Product outlook key takeaways
  • Fig. 23 Japan Next-generation sequencing market: Product movement analysis
  • Fig. 24 Platforms market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sequencing platforms market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Data analysis platforms market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Sample preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Target enrichment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Japan next generation sequencing Market: Application Movement Analysis
  • Fig. 32 Japan next generation sequencing market: Application outlook and key takeaways
  • Fig. 33 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Diagnostics & screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Oncology screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Sporadic cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Inherited cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Companion diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Other diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Research studies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Clinical investigation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Idiopathic diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Inherited diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Non-communicable/other diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Reproductive health market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 NIPT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Aneuploidy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Microdeletions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 PGT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Single gene analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 HLA typing/immune system monitoring market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Metagenomics, epidemiology & drug development market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Agrigenomics & forensics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Consumer genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Japan next generation sequencing market: workflow movement analysis
  • Fig. 58 Japan next generation sequencing market: workflow outlook and key takeaways
  • Fig. 59 Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 NGS library preparation kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Semiautomated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Automated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Primary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Secondary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Tertiary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Japan Next generation sequencing market End-use outlook key takeaways
  • Fig. 69 Japan Next-generation sequencing market: End-use movement analysis
  • Fig. 70 Academic research market estimates and forecast, 2018 - 2030 (USD Million))
  • Fig. 71 Clinical research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Pharmaceutical & biotech entities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Other users market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Market share of key market players- Japan next generation sequencing market
目次
Product Code: GVR-4-68040-156-5

Japan Next Generation Sequencing Market Growth & Trends:

The Japan next generation sequencing market size is expected to reach USD 1,305.67 million by 2030, registering a CAGR of 23.60% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as the development of companion diagnostics and personalized medicine and rising clinical opportunities for NGS technology are projected to drive the market growth. In addition, rising competition in the market owing to high consumer demand and the rising emphasis of market players to develop next-generation sequencing products and services is another vital factor propelling industry demand forward.

With lowering costs, the adoption of next-generation sequencing in the clinical setting is boosting. Moreover, an increase in the demand for clinic-based NGS solutions is anticipated to propel the next generation sequencing industry over the forecast period. The utilization of genome sequencing and MPSS /NGS has become necessary for the diagnosis & analysis of rare diseases, and recognizing therapeutic targets, and for prenatal testing. NGS is anticipated to witness rising adoption in hereditary diseases and infectious disorder treatment. Furthermore, companies are providing products and services based on NGS for rare and hereditary diseases. For instance, in January 2023, Twist Bioscience Corporation, An NGS service provider in Japan, introduced three NGS target enrichment panels to support hereditary cancer research and rare diseases and support diagnostics. Such product launches by key players operating in the country are anticipated to drive market growth over the forecast period.

The developments of companion diagnostics and personalized medicines are anticipated to drive the adoption of next-generation sequencing products and services. Several oncologists expected that NGS combined with companion diagnostics could play a major role in personalized diagnostics and therapeutics, significantly increasing the demand for NGS applications. Furthermore, regulatory authorities are also supporting the use of NGS for companion diagnostics. For instance, in September 2021, the Ministry of Health, Labour, and Welfare (MHLW), Japan, authorized the Oncomine Dx Target Test, a companion diagnostic (CDx) from Thermo Fisher Scientific Inc. The Oncomine test was approved as an NGS-based CDx for lung cancer. Such developments, coupled with regulatory support, are anticipated to boost the market growth over the forecast period.

Japan Next Generation Sequencing Market Report Highlights:

  • Based on product, the consumables segment dominated the industry in 2023 with a revenue share of 74.0%, and this dominance can be attributed to the decrease in sequencing costs and increasing launches of consumables by major players
  • Based on application, the oncology segment was the largest revenue contributor for the industry in 2023. In contrast, the consumer genomics segment is expected to witness the fastest growth owing to the rapid development in personal health awareness, paternity testing, and genealogy
  • Based on workflow, the sequencing segment dominated the market in 2023. The higher revenue of the segment is attributed to the availability of various sequencing platforms
  • Based on technology, the targeted sequencing & resequencing segment dominated the industry in 2023 and is projected to register the highest growth rate during the forecast period
  • Based on end-use, the academic research segment dominated the industry in 2023 due to numerous academic institutes providing bioinformatics courses

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Product
    • 1.1.3. Application
    • 1.1.4. Workflow
    • 1.1.5. End-use
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights

Chapter 3. Japan Next Generation Sequencing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Exponentially decreasing costs for genetic sequencing
      • 3.2.1.2. Development of companion diagnostics and personalized medicine
      • 3.2.1.3. Rise in competition among prominent market entities
      • 3.2.1.4. Rising clinical opportunity for NGS technology
      • 3.2.1.5. Technological advancements in cloud computing and data integration
      • 3.2.1.6. Growing healthcare expenditure supporting development of effective diagnostic & therapeutic procedures for cancer.
      • 3.2.1.7. Increasing prevalence of cancer
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of computational efficiency for data management
      • 3.2.2.2. Non-value-based NGS reimbursement policy and regulation status
      • 3.2.2.3. Challenges associated with NGS implementation.
  • 3.3. Japan Next Generation Sequencing Market Analysis Tools
    • 3.3.1. SWOT analysis; by factor (political & legal, economic, and technological)
    • 3.3.2. Porter's Five Forces Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Japan Next Generation Sequencing Market: Technology Business Analysis

  • 4.1. Next Generation Sequencing Market: Technology Movement Analysis
  • 4.2. Targeted Sequencing & Resequencing
    • 4.2.1. Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.1.1. DNA-based targeted sequencing & resequencing
      • 4.2.1.1.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.2.1.2. RNA-based targeted sequencing & resequencing
      • 4.2.1.2.1. RNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.3. Whole Genome Sequencing
    • 4.3.1. Whole Genome Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.4. Whole Exome Sequencing
    • 4.4.1. Whole Exome Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5. Japan Next Generation Sequencing Market: Product Business Analysis

  • 5.1. Next Generation Sequencing Market: Product Movement Analysis
  • 5.2. Platforms
    • 5.2.1. Platforms Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.1. Sequencing
      • 5.2.1.1.1. Sequencing platforms market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2. Data Analysis
      • 5.2.1.2.1. Data analysis platforms market estimates and forecast, 2018 - 2030 (USD Million
  • 5.3. Consumables
    • 5.3.1. Consumables market estimates and forecast, 2018 - 2030 (USD million)
    • 5.3.2. Sample Preparation
      • 5.3.2.1. Sample preparation market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.3. Target Enrichment
      • 5.3.3.1. Target enrichment market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.4. Others
      • 5.3.4.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Japan Next Generation Sequencing Market: Application Business Analysis

  • 6.1. Next Generation Sequencing Market: Application Movement Analysis
  • 6.2. Oncology
    • 6.2.1. Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2. Diagnostics & Screening
      • 6.2.2.1. Diagnostics & screening market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2. Oncology screening
      • 6.2.2.2.1. Oncology screening market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.2. Sporadic cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.3. Inherited cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.3. Companion diagnostics
      • 6.2.2.3.1. Companion diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.2.2.4. Other diagnostics
      • 6.2.2.4.1. Other diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.2.3. Research Studies
      • 6.2.3.1. Research studies market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3. Clinical investigation
    • 6.3.1. Clinical investigation market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.2. Infectious Diseases
      • 6.3.2.1. Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Idiopathic Diseases
      • 6.3.3.1. Idiopathic diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Inherited Diseases
      • 6.3.4.1. Inherited diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.5. Non-Communicable/Other Diseases
      • 6.3.5.1. Non-communicable/other diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Reproductive Health
    • 6.4.1. Reproductive Health Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2. NIPT
      • 6.4.2.1. NIPT market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.4.2.2. Aneuploidy
      • 6.4.2.2.1. Aneuploidy market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.4.2.3. Microdeletions
      • 6.4.2.3.1. Microdeletions market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. PGT
      • 6.4.3.1. PGT market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. Newborn Genetic Screening
      • 6.4.4.1. Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Single Gene Analysis
      • 6.4.5.1. Single gene analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. HLA Typing/Immune System Monitoring
    • 6.5.1. HLA Typing/Immune System Monitoring Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.6. Metagenomics, Epidemiology & Drug Development
    • 6.6.1. Metagenomics, Epidemiology & Drug Development Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.7. Agrigenomics & Forensics
    • 6.7.1. Agrigenomics & Forensics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.8. Consumer Genomics
    • 6.8.1. Consumer Genomics Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7. Japan Next Generation Sequencing Market: Workflow Business Analysis

  • 7.1. Next Generation Sequencing Market: Workflow Movement Analysis
  • 7.2. Presequencing
    • 7.2.1. Pre-Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.1. NGS library preparation kits
      • 7.2.1.1.1. NGS library preparation kits market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.2.1.2. Semiautomated library preparation
      • 7.2.1.2.1. Semiautomated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.2.1.3. Automated library preparation
      • 7.2.1.3.1. Automated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3. Sequencing
    • 7.3.1. Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4. Data Analysis
    • 7.4.1. Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.2. Primary Data Ngs Analysis
      • 7.4.2.1. Primary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.3. Secondary Data Analysis
      • 7.4.3.1. Secondary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.4. Tertiary Data Analysis
      • 7.4.4.1. Tertiary data analysis market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Japan Next Generation Sequencing Market: End-use Business Analysis

  • 8.1. Next Generation Sequencing Market: End-use Movement Analysis
  • 8.2. Academic Research
    • 8.2.1. Academic Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3. Clinical Research
    • 8.3.1. Clinical Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4. Hospitals & Clinics
    • 8.4.1. Hospitals & Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5. Pharmaceutical & Biotech Entities
    • 8.5.1. Pharmaceutical & Biotech Entities Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6. Other Users
    • 8.6.1. Other Users Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Key company market share analysis, 2023
  • 9.4. Participants Overview
    • 9.4.1. Illumina, Inc
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. QIAGEN
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Thermo Fisher Scientific, Inc
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. BGI
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Pacific Biosciences
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Bio Rad Laboratories
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Oxford Nanopore Technologies, Inc
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Myriad Genetics. Inc.
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Agilent Technologies, Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Eurofins Scientific
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives